Literature DB >> 3732362

The effect of acetaminophen administration on its disposition and body stores of sulphate.

S Hendrix-Treacy, S M Wallace, K W Hindmarsh, G M Wyant, A Danilkewich.   

Abstract

This investigation was designed to investigate the effects of ingestion of multiple therapeutic doses of acetaminophen on the disposition of the drug and on the cosubstrate, sulfate. Nine healthy volunteers and nine outpatients receiving acetaminophen for chronic pain were involved in the study. Volunteers were given a single 650 mg oral dose of acetaminophen. One week later they were given 650 mg of acetaminophen every six hours for five doses. Patients were maintained on their normal treatment and dosage schedules (600 mg every 3 to 8 h) for the study. In healthy volunteers the half-life of acetaminophen after single and multiple dosing was not significantly different. However, the fraction of acetaminophen recovered in the urine as the sulfate conjugate was less and the glucuronide conjugate greater after multiple dosing than after a single of the drug. There was no difference in the percentage recovered as the parent compound between single and multiple dosing. Serum sulfate levels fluctuated over the 6-h period following administration of single and multiple doses of acetaminophen to volunteers. The mean serum sulfate concentration was less after administration of five sequential 650 mg doses of acetaminophen than after a single dose. The renal clearance of inorganic sulfate showed a corresponding decrease. Unexpectedly, patients on chronic acetaminophen therapy exhibited elevated serum sulfate levels (levels higher than the maximum sulfate concentration seen in volunteers).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3732362     DOI: 10.1007/bf00541527

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

1.  Turbidimetric analysis of inorganic sulfate in serum, plasma and urine.

Authors:  F BERGLUND; B SORBO
Journal:  Scand J Clin Lab Invest       Date:  1960       Impact factor: 1.713

2.  Drug biotransformation interactions in man. 3. Acetaminophen and salicylamide.

Authors:  G Levy; H Yamada
Journal:  J Pharm Sci       Date:  1971-02       Impact factor: 3.534

Review 3.  Pharmacokinetic consequences and toxicologic implications of endogenous cosubstrate depletion.

Authors:  G Levy; R E Galinsky; J H Lin
Journal:  Drug Metab Rev       Date:  1982       Impact factor: 4.518

4.  Dose- and time-dependent elimination of acetaminophen in rats: pharmacokinetic implications of cosubstrate depletion.

Authors:  R E Galinsky; G Levy
Journal:  J Pharmacol Exp Ther       Date:  1981-10       Impact factor: 4.030

5.  Pharmacokinetics of salicylamide elimination in man.

Authors:  G Levy; T Matsuzawa
Journal:  J Pharmacol Exp Ther       Date:  1967-05       Impact factor: 4.030

6.  Paracetamol (acetaminophen) clearance in patients with cirrhosis of the liver.

Authors:  P B Andreasen; L Hutters
Journal:  Acta Med Scand Suppl       Date:  1979

7.  Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration.

Authors:  M D Rawlins; D B Henderson; A R Hijab
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

8.  Turbidimetry of inorganic sulfate, ester sulfate, and total sulfur in urine.

Authors:  P Lundquist; J Mårtensson; B Sörbo; S Ohman
Journal:  Clin Chem       Date:  1980-07       Impact factor: 8.327

9.  Serum concentration and renal excretion by normal adults of inorganic sulfate after acetaminophen, ascorbic acid, or sodium sulfate.

Authors:  M E Morris; G Levy
Journal:  Clin Pharmacol Ther       Date:  1983-04       Impact factor: 6.875

10.  Absorption, serum levels and urinary excretion of inorganic sulfate after oral administration of sodium sulfate in the conscious rat.

Authors:  K R Krijgsheld; H Frankena; E Scholtens; J Zweens; G J Mulder
Journal:  Biochim Biophys Acta       Date:  1979-09-03
View more
  11 in total

1.  Decrease of inorganic blood sulfate following treatment with selected antirheumatic drugs: potential consequence for articular cartilage.

Authors:  B J de Vries; P M van der Kraan; W B van den Berg
Journal:  Agents Actions       Date:  1990-03

Review 2.  Pharmacokinetic drug interactions with oral contraceptives.

Authors:  D J Back; M L Orme
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

Review 3.  Can paracetamol (acetaminophen) be administered to patients with liver impairment?

Authors:  Kelly L Hayward; Elizabeth E Powell; Katharine M Irvine; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2015-12-25       Impact factor: 4.335

4.  Paracetamol interaction with oral contraceptive steroids: increased plasma concentrations of ethinyloestradiol.

Authors:  S M Rogers; D J Back; P J Stevenson; S F Grimmer; M L Orme
Journal:  Br J Clin Pharmacol       Date:  1987-06       Impact factor: 4.335

5.  Circadian rhythm of serum sulfate levels in man and acetaminophen pharmacokinetics.

Authors:  D A Hoffman; S M Wallace; R K Verbeeck
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  Increased bioavailability of phenylephrine by co-administration of acetaminophen: results of four open-label, crossover pharmacokinetic trials in healthy volunteers.

Authors:  Hartley C Atkinson; Ioana Stanescu; Isam I Salem; Amanda L Potts; Brian J Anderson
Journal:  Eur J Clin Pharmacol       Date:  2014-12-06       Impact factor: 2.953

7.  The disposition of paracetamol and the accumulation of its glucuronide and sulphate conjugates during multiple dosing in patients with chronic renal failure.

Authors:  U Martin; R M Temple; R J Winney; L F Prescott
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 8.  Paracetamol poisoning in children and hepatotoxicity.

Authors:  A Penna; N Buchanan
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

9.  The effect of chronic paracetamol administration to rats on the glycosaminoglycan content of patellar cartilage.

Authors:  P M van der Kraan; E L Vitters; B J de Vries; W B van den Berg; L B van de Putte
Journal:  Agents Actions       Date:  1990-03

10.  The disposition of paracetamol and its conjugates during multiple dosing in patients with end-stage renal failure maintained on haemodialysis.

Authors:  U Martin; R M Temple; R J Winney; L F Prescott
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.